Dna X (SONM) Accumulated Expenses (2018 - 2026)

Dna X's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Accumulated Expenses fell 89.58% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 89.58% YoY) and the FY2025 annual result came in at $704000.0, up 181.6% from the prior year.
• Accumulated Expenses was $1.6 million for Q1 2026 at Dna X, up from $704000.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $23.1 million in Q3 2024 and bottomed at $250000.0 in Q4 2024.
• A 5-year average of $9.0 million and a median of $10.7 million in 2022 frame the typical range for Accumulated Expenses.
• Peak annual rise in Accumulated Expenses reached 2510.38% in 2024, while the deepest fall reached 97.97% in 2024.
• Dna X's Accumulated Expenses stood at $10.7 million in 2022, then increased by 15.04% to $12.3 million in 2023, then slumped by 97.97% to $250000.0 in 2024, then surged by 181.6% to $704000.0 in 2025, then jumped by 123.86% to $1.6 million in 2026.
• Business Quant data shows SONM's Accumulated Expenses at $1.6 million in Q1 2026, $704000.0 in Q4 2025, and $13.6 million in Q3 2025.